These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32907900)

  • 21. Head-to-head comparison of intensive lifestyle intervention (U-TURN) versus conventional multifactorial care in patients with type 2 diabetes: protocol and rationale for an assessor-blinded, parallel group and randomised trial.
    Ried-Larsen M; Christensen R; Hansen KB; Johansen MY; Pedersen M; Zacho M; Hansen LS; Kofoed K; Thomsen K; Jensen MS; Nielsen RO; MacDonald C; Langberg H; Vaag AA; Pedersen BK; Karstoft K
    BMJ Open; 2015 Dec; 5(12):e009764. PubMed ID: 26656025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of a customised mobile phone text messaging intervention supported by data from activity monitors for improving lifestyle factors related to the risk of type 2 diabetes among women after gestational diabetes: protocol for a multicentre randomised controlled trial (SMART MUMS with smart phones 2).
    Marschner S; Chow C; Thiagalingam A; Simmons D; McClean M; Pasupathy D; Smith BJ; Flood V; Padmanabhan S; Melov S; Ching C; Cheung NW
    BMJ Open; 2021 Sep; 11(9):e054756. PubMed ID: 34535488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding HIV-positive patients' preferences for healthcare services: a protocol for a discrete choice experiment.
    Youssef E; Cooper V; Miners A; Llewellyn C; Pollard A; Lagarde M; Sachikonye M; Sabin C; Foreman C; Perry N; Nixon E; Fisher M
    BMJ Open; 2016 Jul; 6(7):e008549. PubMed ID: 27431895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protocol: investigating the effectiveness and cost benefit of a lifestyle intervention targeting type 2 diabetes in Australia.
    Cloete L; Mitchell BG; Morton D
    BMC Endocr Disord; 2019 Jul; 19(1):74. PubMed ID: 31307434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A protocol for a discrete choice experiment: understanding preferences of patients with cancer towards their cancer care across metropolitan and rural regions in Australia.
    Wong SF; Norman R; Dunning TL; Ashley DM; Lorgelly PK
    BMJ Open; 2014 Oct; 4(10):e006661. PubMed ID: 25344489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences.
    Mühlbacher A; Bethge S
    Eur J Health Econ; 2016 Dec; 17(9):1125-1140. PubMed ID: 26682548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.
    Winkley K; Upsher R; Stahl D; Pollard D; Kasera A; Brennan A; Heller S; Ismail K
    Health Technol Assess; 2020 Jun; 24(28):1-232. PubMed ID: 32568666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Public, medical professionals' and patients' preferences for the allocation of donor organs for transplantation: study protocol for discrete choice experiments.
    Oedingen C; Bartling T; Krauth C
    BMJ Open; 2018 Oct; 8(10):e026040. PubMed ID: 30337317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pragmatic randomised controlled trial referring to a Personalised Self-management SUPport Programme (P-SUP) for persons enrolled in a disease management programme for type 2 diabetes mellitus and/or for coronary heart disease.
    Konerding U; Redaèlli M; Ackermann K; Altin S; Appelbaum S; Biallas B; Bödecker AW; Botzenhardt S; Chermette C; Cichocki M; Dapper I; Dehnen K; Funke C; Gawlik A; Giesen L; Goetz J; Graf C; Hagen B; Heßbrügge M; Höhne PH; Kleinert J; Könnecke H; Küppers L; Kuth N; Lehmann L; Lendt C; Majjouti K; Nacak Y; Neuhausen A; Pilic L; Schneider L; Scholl M; Simic D; Sönnichsen A; Thielmann A; Van der Arend I; Vitinius F; Weltermann B; Wild D; Wilm S; Stock S
    Trials; 2021 Sep; 22(1):659. PubMed ID: 34579783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A protocol for a discrete choice experiment: understanding patient medicine preferences for managing chronic non-cancer pain.
    Shanahan M; Larance B; Nielsen S; Cohen M; Schaffer M; Campbell G
    BMJ Open; 2019 Aug; 9(8):e027153. PubMed ID: 31377695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment.
    Quaife M; Eakle R; Cabrera M; Vickerman P; Tsepe M; Cianci F; Delany-Moretlwe S; Terris-Prestholt F
    BMJ Open; 2016 Jun; 6(6):e010682. PubMed ID: 27354071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the behavioural type-specific approach for type 2 diabetes promote changes in lifestyle? Protocol of a cluster randomised trial in Japan.
    Adachi M; Yamaoka K; Watanabe M; Nemoto A; Tango T
    BMJ Open; 2017 Oct; 7(10):e017838. PubMed ID: 29070640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient Preferences for Attributes of Type 2 Diabetes Mellitus Medications in Germany and Spain: An Online Discrete-Choice Experiment Survey.
    Mansfield C; Sikirica MV; Pugh A; Poulos CM; Unmuessig V; Morano R; Martin AA
    Diabetes Ther; 2017 Dec; 8(6):1365-1378. PubMed ID: 29101681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preferences for pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women at risk of HIV infection: a multicentre protocol for a discrete choice experiment in Brazil.
    Pereira CCA; Torres TS; Luz PM; Hoagland B; Farias A; Brito JDU; Guimarães Lacerda MV; da Silva DAR; Benedetti M; Pimenta MC; Grinsztejn B; Veloso VG
    BMJ Open; 2021 Sep; 11(9):e049011. PubMed ID: 34580095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subsidy programme for gestational diabetes mellitus screening and lifestyle management in rural areas of western China: a study protocol for a multicentre randomised controlled trial.
    Xu T; Lai X; He K; Ma L; Fang H
    BMJ Open; 2021 Jul; 11(7):e045503. PubMed ID: 34230016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the societal and individual preferences for fertility treatment in Australia: study protocol for stated preference discrete choice experiments.
    Botha W; Donnolley N; Shanahan M; Chambers GM
    BMJ Open; 2018 Feb; 8(2):e020509. PubMed ID: 29444788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of a personal health coaching intervention (diabetescoach) in patients with type 2 diabetes: protocol for an open-label, pragmatic randomised controlled trial.
    Hohberg V; Kreppke JN; Kohl J; Seelig E; Zahner L; Streckmann F; Gerber M; König D; Faude O
    BMJ Open; 2022 Jun; 12(6):e057948. PubMed ID: 35649615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-based lifestyle intervention for diabetes (Co-LID study) management rural Nepal: study protocol for a clustered randomized controlled trial.
    Rawal L; Dahal P; Paudel G; Biswas T; Shrestha R; Makaju D; Shrestha A; Yadav U; Sahle BW; Iwashita H; Masuda G; Renzaho A; Shakya P; Shrestha A; Karmacharya B; Sakamoto H; Koju R; Sugishita T
    Trials; 2023 Jul; 24(1):441. PubMed ID: 37403179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study Protocol: The Norfolk Diabetes Prevention Study [NDPS]: a 46 month multi - centre, randomised, controlled parallel group trial of a lifestyle intervention [with or without additional support from lay lifestyle mentors with Type 2 diabetes] to prevent transition to Type 2 diabetes in high risk groups with non - diabetic hyperglycaemia, or impaired fasting glucose.
    Pascale M; Murray N; Bachmann M; Barton G; Clark A; Howe A; Greaves C; Sampson M
    BMC Public Health; 2017 Jan; 17(1):31. PubMed ID: 28056894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.